Mounjaro, Wegovy or Ozempic? A simple guide to how they work, what they cost in India, and what to ask your doctor
If you have been hearing about Mounjaro, Wegovy and Ozempic, you are not alone. These once-weekly injections are everywhere right now, and it is easy to get confused about which is which. Here is a simple, honest guide to what each one does, what it costs and what to ask your doctor.
1 Why is everyone talking about these medicines?
India is often called the diabetes capital of the world, and the numbers explain why. A large ICMR-supported national survey, published in The Lancet Diabetes & Endocrinology in 2023, estimated that about 101 million Indians live with diabetes and another 136 million have prediabetes. Around 29 in every 100 adults had generalised obesity, and almost 40 in 100 carried extra weight around the waist.
Obesity and type 2 diabetes are medical conditions, not a lack of willpower. Hormones, genes, sleep, stress, food environment and medicines all shape how hungry you feel and how your body stores fat. For many people, healthy eating and exercise are essential but are not enough on their own. That gap is what this new group of medicines is trying to fill.
They are built on a simple idea from your own gut. After you eat, your intestines release hormones called incretins. The picture below shows what they do next. Your own GLP-1 is gone within minutes, while these medicines are engineered to last a whole week, which is why they are injected once weekly.
Mounjaro reached India in March 2025 and Wegovy followed in June 2025. Prices have since come down, and key semaglutide patents in India expired in 2026, so the market is changing quickly. That is exactly why a clear, calm guide is useful.
|
IN SHORT • Mounjaro works on two hormone pathways (GIP and GLP-1). Wegovy and Ozempic work on one (GLP-1). • Wegovy and Ozempic are the same medicine, semaglutide, but Wegovy is for weight management and Ozempic is for type 2 diabetes. • In one head-to-head study, tirzepatide (Mounjaro) led to more weight loss on average. The right choice for you still depends on your health, your goals and your budget. |
2 How do they work?
|
Mounjaro Tirzepatide · GIP + GLP-1 |
Wegovy Semaglutide · GLP-1 |
Ozempic Semaglutide · GLP-1 |
|
Works on two gut-hormone receptors, GIP and GLP-1. It helps your body release insulin when your blood sugar is high, lowers glucagon, and helps you feel full so you eat less. Approved use in India Type 2 diabetes and chronic weight management |
Works on the GLP-1 receptor. It helps you feel full sooner and eat less, supports weight loss and also improves blood sugar control. The dose goes up to 2.4 mg. Approved use in India Chronic weight management (overweight or obesity) |
The same medicine as Wegovy (semaglutide) on the same GLP-1 pathway, but at a different dose range (up to 1 mg in India) and prescribed for a different reason. Approved use in India Type 2 diabetes management |
|
What all three do: regulate your appetite • release insulin when your sugar is high • lower glucagon |
Why add a second hormone?
Semaglutide copies one gut hormone, GLP-1. Tirzepatide copies two, GLP-1 and GIP. Think of two locks on the same door: Mounjaro fits both, while Wegovy and Ozempic fit one. Researchers think the second hormone adds to the effect on appetite and blood sugar, although exactly how is still being studied.
Wegovy and Ozempic: same medicine, different settings
Think of Wegovy and Ozempic as one engine with different gear settings. Both contain semaglutide. They differ in the dose range, the pen, and the reason they are prescribed. That is why your doctor will choose between them based on your diagnosis rather than on price or fame alone.
3 What will it cost you?
Here is roughly what one month costs in India, from your starting dose to the highest dose. What you pay depends on the strength your doctor prescribes.
|
Medicine |
Active ingredient |
Starting-dose month |
Highest-dose month |
Weekly dose range |
|
Mounjaro |
Tirzepatide |
₹14,000 (2.5 mg) |
₹27,500 (15 mg) |
2.5–15 mg |
|
Wegovy |
Semaglutide |
₹5,660 (0.25 mg) |
₹16,400 (2.4 mg) |
0.25–2.4 mg |
|
Ozempic |
Semaglutide |
₹5,660 (0.25 mg) |
₹9,100 (1 mg) |
0.25–1 mg |
|
Good to know Mounjaro prices are Lilly India’s published KwikPen MRPs (each pen holds four weekly doses); some pharmacies listed slightly lower prices in November 2026. Ozempic and Wegovy starting-dose prices follow Novo Nordisk India’s cut from 1 April 2026 (₹1,415 a week for 0.25 mg), and higher strengths come from retail listings. Packs hold different numbers of doses, so ask your pharmacist what a month’s supply costs for your dose. Prices change, so check the current MRP before you buy. |
Why is the range so wide? Because the cost rises with the dose. You usually start on a low dose and step up over several months, so the first month is often the cheapest one. When you plan your budget, ask your doctor which dose you are likely to end up on, and remember that these are long-term treatments, not a one-month course.
4 Does one help you lose more weight?
In a 72-week head-to-head study of adults with obesity (without diabetes), people taking tirzepatide lost an average of 20.2% of their body weight, compared with 13.7% on semaglutide. That is about 22.8 kg versus 15.0 kg.
|
|
About the study (SURMOUNT-5) • 751 adults with obesity, without type 2 diabetes • 72 weeks, at the highest dose each person could tolerate • Waist size: about 18 cm smaller vs 13 cm smaller • Stopped because of stomach side effects: 2.7% vs 5.6% |
These are averages. Your own result may be higher or lower. If you have type 2 diabetes, a separate head-to-head study found that tirzepatide lowered HbA1c more than semaglutide 1 mg.
Source: Aronne et al., N Engl J Med 2025 (SURMOUNT-5); Frías et al., N Engl J Med 2021 (SURPASS-2).
Reading these numbers sensibly
A 20% weight loss means that a person who weighs 100 kg lost about 20 kg on average. That is a large change, but it is an average across many people, and some lost more while others lost less. These medicines are also meant to work together with healthy eating, regular movement and good sleep, not to replace them. Doctors look at more than the number on the scale, including your waist, blood sugar, blood pressure and how you feel day to day.
5 What should you know before you start?
|
Side effects are common Nausea, vomiting, diarrhoea and constipation can happen, especially while your dose is being increased. Contact your doctor if you have severe or lasting stomach pain or vomiting. |
You need a prescription Your doctor will assess you, raise your dose slowly and follow your progress. |
|
Don’t mix or switch on your own Never use Mounjaro together with a semaglutide product (Wegovy or Ozempic), and don’t switch between them without medical advice. |
Tell your doctor if… You or a close relative has had medullary thyroid cancer or MEN 2, you are pregnant or planning a pregnancy, or you have had kidney, gallbladder or pancreas problems. |
Many doctors suggest eating smaller meals, eating slowly, limiting very oily or greasy food and drinking enough water while your dose is being increased. These small habits can ease stomach side effects. If symptoms are troubling, speak to your doctor rather than stopping or changing the dose yourself.
The right choice depends on your diagnosis, weight, other health conditions, goals, how you tolerate the medicine and what you can afford. Your doctor will help you weigh these.
6 Questions you may be wondering about
|
1 |
Are Ozempic and Wegovy the same medicine? They share the same active ingredient, semaglutide, but they are not interchangeable. In India Ozempic is approved for type 2 diabetes and Wegovy for weight management, at different doses. |
|
2 |
Which one will help me lose more weight? On average, tirzepatide (Mounjaro) led to more weight loss than semaglutide in a head-to-head study (20.2% vs 13.7%). Results differ from person to person, so let your doctor guide the choice. |
|
3 |
How do I take GLP-1 injections? Once a week, on the same day each week, as a small injection under the skin of your tummy, thigh or upper arm. You can take it at any time of day, with or without food. Use a new needle each time and change the spot every week. You start on a low dose and your doctor raises it step by step, usually every four weeks or so. Keep unused pens in the fridge. If you miss a dose, check the leaflet for your medicine (Mounjaro: within 4 days, Ozempic and Wegovy: within 5 days) and never take two doses together. |
|
4 |
Will I have to take it for life? Obesity and type 2 diabetes are long-term conditions, and weight is often regained after stopping the medicine. How long you continue is a decision to make with your doctor. |
|
5 |
Can I use it to lose a few kilos quickly? No. These medicines are not for cosmetic weight loss. For weight management, Mounjaro’s India approval covers adults with a BMI of 30 or more, or 27 or more with at least one weight-related condition. |
7 Before your appointment
|
Questions to ask your doctor • Is this medicine right for my condition and my BMI? • Which dose will I start on, and how will it be increased? • Which side effects should I watch for, and when should I call you? • What will it cost me over the next few months? • How will we check my progress? |
|
THE SHORT VERSION Mounjaro works on both GIP and GLP-1 receptors. Wegovy and Ozempic contain semaglutide and work on GLP-1. They are not two names for the same plan: they are approved for different uses and come in different doses. The best option for you is the one that is right for your health and that you can stick with. |
|
Talk to your doctor before you start, stop or switch any of these medicines. They are not meant for cosmetic weight loss. |
Sources
1. Aronne LJ, Horn DB, le Roux CW, et al. Tirzepatide as compared with semaglutide for the treatment of obesity. N Engl J Med. 2025;393:26–36. doi:10.1056/NEJMoa2416394
2. Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. N Engl J Med. 2021;385:503–515. doi:10.1056/NEJMoa2107519
3. Anjana RM, Unnikrishnan R, Mohan D, et al. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study. Lancet Diabetes Endocrinol. 2023;11:474–489. (Figures as reported by Scroll.in, 8 June 2023.)
4. Eli Lilly and Company (India). Mounjaro KwikPen India launch: approved indications, strengths and MRPs. lilly.com/in/news/press-releases/lilly-launches-mounjaro-kwikpen-tirzepatide-to-advance-care-for-adults-living-with-type-2-diabetes-and-obesity
5. Novo Nordisk India. Price of ₹202/day for the starting dose of Ozempic and Wegovy, effective 1 April 2026 (via BioSpectrum India). biospectrumindia.com/news/16/27598
6. Business Today. Novo Nordisk cuts Wegovy prices by 37% to counter Lilly’s Mounjaro (Wegovy India launch June 2025; Mounjaro March 2025). 11 November 2025. businesstoday.in
7. PharmEasy. Mounjaro, Wegovy and Ozempic price in India. Pages updated 1 November 2026. pharmeasy.in/glp-1/
A note from us: This guide is for information only and does not replace advice from your doctor. Prices and approvals can change, so check the current details before you buy.

